Cardiovascular Outcomes Research Laboratories (CORELAB), Division of Cardiac Surgery, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California; Division of Cardiac Surgery, University of California Los Angeles, Los Angeles, Los Angeles, California.
Cardiovascular Outcomes Research Laboratories (CORELAB), Division of Cardiac Surgery, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.
J Surg Res. 2020 Feb;246:457-463. doi: 10.1016/j.jss.2019.09.016. Epub 2019 Nov 6.
Readmissions after colorectal operations adversely impact patient recovery and are associated with about $300 million in additional health care expenditure in the United States alone. The present study aimed to characterize nonelective, short-term readmissions of colorectal surgery patients who underwent colostomy.
The Nationwide Readmissions Database was used to identify patients who received a colostomy from 2010 to 2015. Patients were stratified by discharge-to-readmission interval: immediate (within 7 d) and delayed (7-30 d). Nonparametric trend analysis and multivariable regression were performed to identify predictors of immediate and delayed readmission.
Of an estimated 376,693 operations requiring colostomies during the study, in-hospital survival was 92.3%, with higher rates after elective compared with nonelective operations (96.5 versus 90.8%, P < 0.001). Overall, 15.3% patients undergoing elective and nonelective colostomy creation returned to the hospital within 30 d, with 41.6% of these readmissions occurring by the first week of discharge (immediate). Readmission rates and proportion of immediate and delayed groups did not significantly change over the 6-year study period. Nonhome discharge increased the odds of immediate (AOR 1.25, 95% CI 1.17-1.34) and delayed readmission (AOR 1.44, 95% CI 1.35-1.54). Annually, immediate and delayed rehospitalizations after colostomy creation were responsible for $64 and 82 million in excess costs, respectively.
Colostomy creation is associated with a steady and high rate of rehospitalization. Nonhome discharge, in addition to several patient comorbidities, is associated with higher odds of readmission. Programs aimed at reduction of immediate readmission are warranted.
结直肠手术后的再入院对患者的康复产生不利影响,仅在美国就导致额外增加约 3 亿美元的医疗保健支出。本研究旨在分析行结肠造口术的结直肠手术患者中非择期、短期再入院的特征。
使用全国再入院数据库(Nationwide Readmissions Database)确定 2010 年至 2015 年期间接受结肠造口术的患者。根据出院至再入院的时间间隔将患者分层:即刻(7 天内)和延迟(7-30 天)。采用非参数趋势分析和多变量回归分析来确定即刻和延迟再入院的预测因素。
在研究期间,估计有 376693 例需要结肠造口术的手术,院内生存率为 92.3%,择期手术的生存率高于非择期手术(96.5%比 90.8%,P<0.001)。总体而言,15.3%接受择期和非择期结肠造口术的患者在 30 天内返回医院,其中 41.6%的再入院发生在出院后的第一周(即刻)。在 6 年的研究期间,再入院率和即刻及延迟组的比例没有明显变化。非家庭出院增加了即刻(AOR 1.25,95%CI 1.17-1.34)和延迟再入院(AOR 1.44,95%CI 1.35-1.54)的可能性。每年,结肠造口术后即刻和延迟再入院分别导致 6400 万美元和 8200 万美元的额外费用。
结肠造口术与稳定且高的再入院率相关。非家庭出院以及多种患者合并症与更高的再入院风险相关。有必要制定旨在减少即刻再入院的计划。